SCHEMBL3346693

SCHEMBL3346693

CCOC(=O)c1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 11/20 0.62
HRH3 Q9Y5N1 1/20 0.52
NPSR1 Q6W5P4 2/20 0.49
MAPT P10636 1/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49
PDE4D Q08499 2/20 0.49
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401143 0.88 GPR119 (0.62) GPR119HRH3MAPTPDE4APDE4B
SCHEMBL3622118 0.87 GPR119 (0.57) GPR119HRH3PDE4APDE4BPDE4C
SCHEMBL30102016 0.86 GPR119 (0.64) GPR119HRH3PDE4APDE4BPDE4C
SCHEMBL1372747 0.86 GPR119 (0.64) GPR119HRH3PDE4APDE4BPDE4C
SCHEMBL3343638 0.86 GPR119 (0.64) GPR119HRH3PDE4APDE4BPDE4C
SCHEMBL20138026 0.85 GPR119 (0.63) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL5525265 0.85 GPR119 (0.63) GPR119HRH3PDE4APDE4BPDE4C
SCHEMBL30812182 0.84 GPR119 (0.50) GPR119NPSR1MAPTPDE4APDE4B
SCHEMBL601775 0.84 DGAT1 (0.43) GPR119HRH3MAPTPDE4BALDH1A1
SCHEMBL601774 0.84 DGAT1 (0.43) GPR119HRH3MAPTPDE4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed